Cowen & Co. analyst J. Derrick Wood maintains Monday.Com (NASDAQ:MNDY) with a Outperform and raises the price target from $150 to $180.
Evercore ISI Group Upgrades BioCryst Pharmaceuticals to Outperform, Announces $16 Price Target
Evercore ISI Group analyst Liisa Bayko upgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from In-Line to Outperform and announces $16 price target.